CpG DNA as a Th1 Trigger

No abstract is available for this paper.

• Publication year

  2000

• Venue

  International Archives of Allergy and Immunology

• Publication date

  2000-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1159/000024303PMID 10705218
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Poly‐guanosine motifs costimulate antigen‐reactive CD8 T cells while bacterial CpG‐DNA affect T‐cell activation via antigen‐presenting cell‐derived cytokines

  2000cited by this paper
• CpG DNA co-stimulates antigen-reactive T cells.

  2000cited by this paper
• The Role of Cell Surface Receptors in the Activation of Human B Cells by Phosphorothioate Oligonucleotides

  2000cited by this paper
• CpG-DNA-Mediated Transient Lymphadenopathy Is Associated with a State of Th1 Predisposition to Antigen-Driven Responses1

  2000cited by this paper
• Bacterial CpG DNA activates immune cells to signal infectious danger.

  1999cited by this paper
• Oligodeoxynucleotides containing CpG motifs induce IL‐12, IL‐18 and IFN‐γ production in cells from allergic individuals and inhibit IgE synthesis in vitro

  1999cited by this paper
• CpG‐oligodeoxynucleotides co‐stimulate primary T cells in the absence of antigen‐presenting cells

  1999cited by this paper
• Route and Method of Delivery of DNA Vaccine Influence Immune Responses in Mice and Non-Human Primates

  1999cited by this paper
• Synthetic oligodeoxynucleotides containing CpG motifs enhance immunogenicity of a peptide malaria vaccine in Aotus monkeys.

  1999cited by this paper
• Oligodeoxynucleotides Containing Palindrome Sequences with Internal 5′-CpG-3′ Act Directly on Human NK and Activated T Cells to Induce IFN-γ Production In Vitro

  1999cited by this paper
• Oligonucleotide therapy of allergic asthma.

  1999cited by this paper
• Inhibition of allergic inflammation in the lung by plasmid DNA allergen immunization

  1999cited by this paper
• Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors.

  1999cited by this paper
• CpG DNA as mucosal adjuvant.

  1999cited by this paper
• DNA–Based Immunization for Asthma

  1999cited by this paper
• Immunostimulatory oligodeoxynucleotides promote protective immunity and provide systemic therapy for leishmaniasis via IL-12- and IFN-gamma-dependent mechanisms.

  1999cited by this paper
• Guanosine‐rich oligodeoxynucleotides induce proliferation of macrophage progenitors in cultures of murine bone marrow cells

  1999cited by this paper
• Immunostimulatory DNA as an Adjuvant in Vaccination against Leishmania major

  1999cited by this paper
• CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells.

  1999cited by this paper
• Repeated Administration of Synthetic Oligodeoxynucleotides Expressing CpG Motifs Provides Long-Term Protection against Bacterial Infection

  1999cited by this paper
• Exacerbation of Viral and Autoimmune Animal Models for Multiple Sclerosis by Bacterial DNA

  1999cited by this paper
• CpG DNA and LPS induce distinct patterns of activation in human monocytes

  1999cited by this paper
• Enhancement of antigen-presenting cell surface molecules involved in cognate interactions by immunostimulatory DNA sequences.

  1999cited by this paper
• DNA activates human immune cells through a CpG sequence‐dependent manner

  1999cited by this paper
• Multivalent cross-linking of membrane Ig sensitizes murine B cells to a broader spectrum of CpG-containing oligodeoxynucleotide motifs, including their methylated counterparts, for stimulation of proliferation and Ig secretion.

  1999cited by this paper
• CpG oligodeoxynucleotides do not require TH1 cytokines to prevent eosinophilic airway inflammation in a murine model of asthma.

  1999cited by this paper
• Oligodeoxynucleotides containing palindrome sequences with internal 5'-CpG-3' act directly on human NK and activated T cells to induce IFN-gamma production in vitro.

  1999cited by this paper
• Intra-articularly localized bacterial DNA containing CpG motifs induces arthritis

  1999cited by this paper
• Immunostimulatory CpG-oligodeoxynucleotides cause extramedullary murine hemopoiesis.

  1999cited by this paper
• Antagonism of immunostimulatory CpG-oligodeoxynucleotides by quinacrine, chloroquine, and structurally related compounds.

  1998cited by this paper
• The Influence of DNA Sequence on the Immunostimulatory Properties of Plasmid DNA Vectors

  1998cited by this paper
• CpG motifs in bacterial DNA activate leukocytes through the pH-dependent generation of reactive oxygen species.

  1998cited by this paper
• CpG DNA Rescue from Anti-IgM-Induced WEHI-231 B Lymphoma Apoptosis via Modulation of IκBα and IκBβ and Sustained Activation of Nuclear Factor-κB/c-Rel

  1998cited by this paper
• CpG‐DNA‐specific activation of antigen‐presenting cells requires stress kinase activity and is preceded by non‐specific endocytosis and endosomal maturation

  1998cited by this paper
• Infection of Mice with Mycobacterium bovis–Bacillus Calmette-Guérin (BCG) Suppresses Allergen-induced Airway Eosinophilia

  1998cited by this paper
• DNA Immunotherapeutics: New Potential Treatment Modalities for Allergic Disease

  1998cited by this paper
• Reduction of Antigen Expression from DNA Vaccines by Coadministered Oligodeoxynucleotides

  1998cited by this paper
• Type I Interferon-mediated Stimulation of T Cells by CpG DNA

  1998cited by this paper
• The role of CpG dinucleotides in DNA vaccines.

  1998cited by this paper
• Rapid induction of mitogen-activated protein kinases by immune stimulatory CpG DNA.

  1998cited by this paper
• CpG DNA rescue from anti-IgM-induced WEHI-231 B lymphoma apoptosis via modulation of I kappa B alpha and I kappa B beta and sustained activation of nuclear factor-kappa B/c-Rel.

  1998cited by this paper
• Modulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma.

  1998cited by this paper
• Bacterial DNA as immune cell activator.

  1998cited by this paper
• CpG DNA, a novel immune enhancer for systemic and mucosal immunization with influenza virus.

  1998cited by this paper
• Inhibition of IgE formation and allergic inflammation by allergen gene immunization

  1998cited by this paper
• DNA as an Adjuvant: Capacity of Insect DNA and Synthetic Oligodeoxynucleotides to Augment T Cell Responses to Specific Antigen

  1998cited by this paper
• Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells

  1998cited by this paper
• Inhibition of an established allergic response to ovalbumin in BALB/c mice by killed Mycobacterium vaccae

  1998cited by this paper
• Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs.

  1998cited by this paper
• Immunostimulatory DNA sequences inhibit IL-5, eosinophilic inflammation, and airway hyperresponsiveness in mice.

  1998cited by this paper
• Immunostimulatory DNA is a potent mucosal adjuvant.

  1998cited by this paper
• Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: a role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA.

  1998cited by this paper
• CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen.

  1998cited by this paper
• Twenty proteins containing a C-terminal SOCS box form five structural classes.

  1998cited by this paper
• CpG DNA induces sustained IL-12 expression in vivo and resistance to Listeria monocytogenes challenge.

  1998cited by this paper
• CpG oligodeoxyribonucleotides rescue mature spleen B cells from spontaneous apoptosis and promote cell cycle entry.

  1998cited by this paper
• Cutting Edge: Modulation of Airway Inflammation by CpG Oligodeoxynucleotides in a Murine Model of Asthma

  1998cited by this paper
• CpG oligodeoxynucleotides trigger protective and curative Th1 responses in lethal murine leishmaniasis.

  1998cited by this paper
• Bacterial DNA as an evolutionary conserved ligand signalling danger of infection to immune cells

  1998cited by this paper
• Bacterial DNA causes septic shock

  1997cited by this paper
• IGIF Does Not Drive Th1 Development but Synergizes with IL-12 for Interferon-γ Production and Activates IRAK and NFκB

  1997cited by this paper
• Mac-1 (CD11b/CD18) is an oligodeoxynucleotide-binding protein

  1997cited by this paper
• CpG motifs in bacterial DNA cause inflammation in the lower respiratory tract.

  1997cited by this paper
• Tap: a novel cellular protein that interacts with tip of herpesvirus saimiri and induces lymphocyte aggregation.

  1997cited by this paper
• Bacterial DNA-induced NK cell IFN-gamma production is dependent on macrophage secretion of IL-12.

  1997cited by this paper
• Oligonucleotide Adjuvants for T Helper 1 (Th1)–specific Vaccination

  1997cited by this paper
• Bacterial DNA-Induced NK Cell IFN-γ Production Is Dependent on Macrophage Secretion of IL-12

  1997cited by this paper
• Early BCG vaccination and development of atopy.

  1997cited by this paper
• CpG‐containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: A new class of vaccine adjuvants

  1997cited by this paper
• IGIF does not drive Th1 development but synergizes with IL-12 for interferon-gamma production and activates IRAK and NFkappaB.

  1997cited by this paper
• Macrophages sense pathogens via DNA motifs: induction of tumor necrosis factor‐α‐mediated shock

  1997cited by this paper
• Immunostimulatory DNA: Sequence‐dependent production of potentially harmful or useful cytokines

  1997cited by this paper
• Mitogenicity of DNA from different organisms for murine B cells.

  1997cited by this paper
• CpG Oligodeoxynucleotides Act as Adjuvants that Switch on T Helper 1 (Th1) Immunity

  1997cited by this paper
• Innate immunity: impact on the adaptive immune response.

  1997cited by this paper
• Contribution of CpG motifs to the immunogenicity of DNA vaccines.

  1997cited by this paper
• Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants

  1997cited by this paper
• Allergy and modern society: does 'Western life style' promote the development of allergies?

  1997cited by this paper
• Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization.

  1997cited by this paper
• IFN-gamma promotes IL-6 and IgM secretion in response to CpG motifs in bacterial DNA and oligodeoxynucleotides.

  1996cited by this paper
• Oligodeoxynucleotide Modifications Determine the Magnitude of B Cell Stimulation by CpG Motifs

  1996cited by this paper
• Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization.

  1996cited by this paper
• Immunostimulatory DNA Sequences Necessary for Effective Intradermal Gene Immunization

  1996cited by this paper
• Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA.

  1996cited by this paper
• CpG DNA rescue of murine B lymphoma cells from anti-IgM-induced growth arrest and programmed cell death is associated with increased expression of c-myc and bcl-xL.

  1996cited by this paper
• Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase

  1996cited by this paper
• Activation of human B cells by phosphorothioate oligodeoxynucleotides.

  1996cited by this paper
• Dual function of Drosophila cells as APCs for naive CD8+ T cells: implications for tumor immunotherapy.

  1996cited by this paper
• The Inverse Association Between Tuberculin Responses and Atopic Disorder

  1996cited by this paper
• Bacterial DNA induces murine interferon-gamma production by stimulation of interleukin-12 and tumor necrosis factor-alpha.

  1996cited by this paper
• Rapid immune activation by CpG motifs in bacterial DNA. Systemic induction of IL-6 transcription through an antioxidant-sensitive pathway.

  1996cited by this paper
• The expanding universe of T-cell subsets: Th1, Th2 and more.

  1996cited by this paper
• Macrophages ingest and are activated by bacterial DNA.

  1996cited by this paper
• Immune activation by bacterial DNA: a new genetic code.

  1996cited by this paper
• Dendritic cells process exogenous viral proteins and virus‐like particles for class I presentation to CD8+ cytotoxic T lymphocytes

  1996cited by this paper
• An innate immune defense mechanism based on the recognition of CpG motifs in microbial DNA.

  1996cited by this paper
• Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo

  1996cited by this paper
• Bacterial DNA induces NK cells to produce IFN-gamma in vivo and increases the toxicity of lipopolysaccharides.

  1996cited by this paper
• A new foreign policy: MHC class I molecules monitor the outside world.

  1996cited by this paper
• Lymphocyte activation by CpG dinucleotide motifs in prokaryotic DNA.

  1996cited by this paper

• Combination adjuvant improves influenza virus immunity by downregulation of immune homeostasis genes in lymphocytes

  2025cites this paper
• Co‐Delivery of Multiple Toll‐Like Receptor Agonists and Avian Influenza Hemagglutinin on Protein Nanoparticles Enhances Vaccine Immunogenicity and Efficacy

  2025cites this paper
• Induction of sustained antibody responses by subcutaneous administration of immunostimulatory Takumi-shaped CpG DNA hydrogel loaded with Japanese cedar pollen antigen Cryj1 in mice

  2025cites this paper
• Synthetic Multicomponent Nanovaccines Based on the Molecular Co-assembly of β-Peptides Protect against Influenza A Virus.

  2023cites this paper
• A simple self-adjuvanting biomimetic nanovaccine self-assembled with the conjugate of phospholipids and nucleotides can induce a strong cancer immunotherapeutic effect.

  2020cites this paper
• TLR9 agonist adsorbed to alum adjuvant prevents asthma‐like responses induced by Blomia tropicalis mite extract

  2019cites this paper
• Flagellin-deficient outer membrane vesicles as adjuvant induce cross-protection of Salmonella Typhimurium outer membrane proteins against infection by heterologous Salmonella serotypes.

  2018cites this paper
• Distinct Effects of Monophosphoryl Lipid A, Oligodeoxynucleotide CpG, and Combination Adjuvants on Modulating Innate and Adaptive Immune Responses to Influenza Vaccination

  2017cites this paper
• CpG oligodeoxynucleotide nanomedicines for the prophylaxis or treatment of cancers, infectious diseases, and allergies

  2017cites this paper
• Designer outer membrane vesicles as immunomodulatory systems – Reprogramming bacteria for vaccine delivery

  2017cites this paper
• Phage display as a promising approach for vaccine development

  2016cites this paper
• CpG DNA facilitate the inactivated transmissible gastroenteritis virus in enhancing the local and systemic immune response of pigs via oral administration

  2016cites this paper
• Functional Toll-Like Receptor 9 Expression and CXCR3 Ligand Release in Pulmonary Sarcoidosis.

  2016cites this paper
• Hemokinin-1 Molecular Adjuvant: An Approach to Enhance the Efficacy of Influenza Vaccine

  2015cites this paper
• Biodegradable particles as vaccine delivery systems

  2014cites this paper
• Development of a Poly (lactic-co-glycolic acid) Particle Vaccine to Protect Against House Dust Mite Induced Allergy

  2014cites this paper
• Neonatal Vaccination with Plasmid DNA Encoding Cyn d 1 Effectively Prevents Allergic Responses in Mice

  2014cites this paper
• New Generation Vaccines : Need for Safe and Improved Adjuvants

  2014cites this paper
• Identification of a new immunogenic candidate conferring protection against Brucella melitensis infection in mice.

  2014cites this paper
• Properties and prospects of adjuvants in influenza vaccination - messy precipitates or blessed opportunities?

  2013cites this paper
• Sinonasal Epithelial Cell Expression of Toll-Like Receptor 9 is Elevated in Cystic Fibrosis-Associated Chronic Rhinosinusitis

  2013cites this paper
• Immunobioengineering Approaches Towards Combinatorial Delivery of Immune-Modulators and Antigens

  2013cites this paper
• Toll-like receptor 9 gene polymorphisms in polymyalgia rheumatica and giant cell arteritis

  2012cites this paper
• Induction of Specific Th1 Responses and Suppression of IgE Antibody Formation by Vaccination with Plasmid DNA Encoding Cyn d 1

  2012cites this paper
• Immunocompatibility of Bacteriophages as Nanomedicines

  2012cites this paper
• Systemic immunization with an epitope-based vaccine elicits a Th1-biased response and provides protection against Helicobacter pylori in mice.

  2012cites this paper
• Associations of allergic sensitization and clinical phenotypes with innate immune response genes polymorphisms are modified by house dust mite allergen exposure

  2011cites this paper
• Immunomodulation of bivalent Newcastle disease DNA vaccine induced immune response by co-delivery of chicken IFN-γ and IL-4 genes.

  2011cites this paper
• Molecular basis of the mucosal immune system: from fundamental concepts to advances in liposome-based vaccines.

  2010cites this paper
• CpG Oligodeoxynucleotides as TLR9 Agonists

  2010cites this paper
• In vitro and in vivo effects of CpG-Oligodeoxynucleotides (CpG-ODN) on murine transitional cell carcinoma and on the native murine urinary bladder wall.

  2009cites this paper
• Structural requirements for uptake and recognition of CpG oligonucleotides.

  2008cites this paper
• Immunstimulative CpG-Oligodeoxynukleotide (CpG-ODN) im orthotopen murinen Transitionalzellkarzinom (TCC)-Modell

  2008cites this paper
• CpG oligonucleotides as adjuvant in therapeutic vaccines against parasitic infections.

  2008cites this paper
• [Presence of bacterial DNA in valvular tissue of patients with chronic rheumatic heart disease].

  2007cites this paper
• In vivo effects of oligodeoxynucleotides containing synthetic immunostimulatory motifs in the immune response to swine streptococcic septicemia vaccine in weaned piglets.

  2007cites this paper
• The identification of two protective DNA vaccines from a panel of five plasmid constructs encoding Brucella melitensis 16M genes.

  2007cites this paper
• GM food nightmare unfolding in the regulatory sham

  2007cites this paper
• Vaccination with porcine reproductive and respiratory syndrome killed virus vaccine and immunostimulatory oligodeoxynucleotides induces specific immunity in piglets.

  2007cites this paper
• Vaccination with Newcastle disease vaccine and CpG oligodeoxynucleotides induces specific immunity and protection against Newcastle disease virus in SPF chicken.

  2007cites this paper
• CpG oligodeoxynucleotides augment the immune responses of piglets to swine Pasteurella multocida living vaccine in vivo.

  2007cites this paper
• Effects of intravenous and subcutaneous administration on the pharmacokinetics, biodistribution, cellular uptake and immunostimulatory activity of CpG ODN encapsulated in liposomal nanoparticles.

  2007cites this paper
• Protection of Chickens Against a Lethal Challenge of Escherichia coli by a Vaccine Containing CpG Oligodeoxynucleotides as an Adjuvant

  2007cites this paper
• Presencia de ADN bacteriano en el tejido valvular de pacientes con cardiopatía reumática crónica

  2007cites this paper
• Developments in Avian Influenza Virus Vaccines

  2007cites this paper
• Microbial Ecology in Health and Disease

  2007cites this paper
• Co-administration of porcine-specific CpG oligodeoxynucleotide enhances the immune responses to pseudorabies attenuated virus vaccine in newborn piglets in vivo.

  2006cites this paper
• Production of Monoclonal Antibodies

  2006cites this paper
• The efficacy of CpG oligodinucleotides, in combination with conventional adjuvants, as immunological adjuvants to swine streptococcic septicemia vaccine in piglets in vivo.

  2006cites this paper
• Effects of CpG ODN on CD4+ and CD8+ T subpopulations in the immune response to porcine reproductive and respiratory syndrome killed virus vaccine.

  2006cites this paper
• Oral administration of CpG‐ODNs suppresses antigen‐induced asthma in mice

  2006cites this paper
• CpG oligodinucleotides induce strong humoral and cellular responses to swine streptococcic septicemia vaccine in piglets in vivo.

  2006cites this paper
• Inhibition of the hepatitis B virus replication in vitro by an oligodeoxynucleotide containing cytidine-guanosine motifs.

  2006cites this paper
• TLR7 Ligands Induce Higher IFN-α Production in Females1

  2006cites this paper
• Effect of transgenic expression of porcine interleukin-6 gene and CpG sequences on immune responses of newborn piglets inoculated with Pseudorabies attenuated vaccine.

  2006cites this paper
• Endotoxin and mammalian host responses during experimental disease.

  2006cites this paper
• Microbial nucleic acids pay a Toll in kidney disease.

  2006cites this paper
• Common human Toll‐like receptor 9 polymorphisms and haplotypes: association with atopy and functional relevance

  2005cites this paper
• Resistance to influenza A virus infection by antigen-conjugated CpG oligonucleotides, a novel antigen-specific immunomodulator.

  2005cites this paper
• DNA vaccination against Japanese cedar pollinosis in dogs suppresses type I hypersensitivity by controlling lesional mast cells.

  2005cites this paper
• Covalent conjugation of polyethyleneimine on biodegradable microparticles for delivery of plasmid DNA vaccines.

  2005cites this paper
• Current developments in viral DNA vaccines: shall they solve the unsolved?

  2005cites this paper
• Enhanced HIV‐1 specific immune response by CpG ODN and HIV‐1 immunogen‐pulsed dendritic cells confers protection in the Trimera murine model of HIV‐1 infection

  2005cites this paper
• Anti‐HBV effects of CpG oligodeoxynucleotide‐activated peripheral blood mononuclear cells from patients with chronic hepatitis B

  2005cites this paper
• CpG-Motive im Mausmodell für allergisches Asthma – Einfluß immunstimulatorischer DNA-Sequenzen auf die Entwicklung der allergischen Sensibilisierung und bronchialen Hyperreagibilität

  2005cites this paper
• A Toll for lupus

  2005cites this paper
• A CpG-containing oligodeoxynucleotide as an efficient adjuvant counterbalancing the Th1/Th2 immune response in diphtheria-tetanus-pertussis vaccine.

  2005cites this paper
• Antineoplastic effect of immunostimulatory DNA (CpG-ODN) in a murine C57-BL6/MB-49 transitional cell carcinoma model.

  2004cites this paper
• Immunomodulation in asthma: a distant dream or a close reality?

  2004cites this paper
• Signaling danger: toll-like receptors and their potential roles in kidney disease.

  2004cites this paper
• Activation of toll‐like receptor‐9 induces progression of renal disease in MRL‐Fas(lpr) mice

  2004cites this paper
• Animal models of type I allergy using recombinant allergens.

  2004cites this paper
• Protection of Neonatal Chicks Against a Lethal Challenge of Escherichia coli Using DNA Containing Cytosine-Phosphodiester-Guanine Motifs

  2004cites this paper
• Systemic Th1 Immunization of Mice against Helicobacter pylori Infection with CpG Oligodeoxynucleotides as Adjuvants Does Not Protect from Infection but Enhances Gastritis

  2004influential citation
• Pulmonary delivery of respiratory syncytial virus DNA vaccines using macroaggregated albumin particles.

  2004cites this paper
• Mucosal Immunization with Helicobacter, CpG DNA, and Cholera Toxin Is Protective

  2003cites this paper
• CD40 ligand (CD154) improves the durability of respiratory syncytial virus DNA vaccination in BALB/c mice.

  2003cites this paper
• Bacterial LPS and CpG DNA differentially induce gene expression profiles in mouse macrophages.

  2003cites this paper
• Bacterial LPS and CpG DNA differentially induce gene expression profiles in mouse macrophages

  2003cites this paper
• Safety of CpG Oligodeoxynucleotides in Veterinary Species

  2003cites this paper
• Protection of Chickens against Escherichia coli Infections by DNA Containing CpG Motifs

  2003cites this paper
• OM197-MP-AC induces the maturation of human dendritic cells and promotes a primary T cell response.

  2003cites this paper
• Superantigens and Bacterial DNA as Cytokine Inducers in Gram-Positive Sepsis

  2003cites this paper
• Review Safety of CpG Oligodeoxynucleotides in Veterinary Species

  2003cites this paper
• Bacterial CpG-DNA aggravates immune complex glomerulonephritis: role of TLR9-mediated expression of chemokines and chemokine receptors.

  2003influential citation
• CpG DNA , and Cholera Toxin Is Protective , Helicobacter Mucosal Immunization with

  2002cites this paper
• Maternal and newborn immunization with a human immunodeficiency virus‐1 immunogen in a rodent model

  2002cites this paper
• Inflammatogenic Properties of Immunostimulatory DNA Sequences

  2002cites this paper
• Improved Immunogenicity and Efficacy of the Recombinant 19-Kilodalton Merozoite Surface Protein 1 by the Addition of Oligodeoxynucleotide and Aluminum Hydroxide Gel in a Murine Malaria Vaccine Model

  2002cites this paper
• Generation of Th1 immune responses to inactivated, gp120-depleted HIV-1 in mice with a dominant Th2 biased immune profile via imunostimulatory oligonucleotides—relevance to AIDS vaccines in developing countries

  2002cites this paper
• CpG-containing oligodeoxynucleotides, in combination with conventional adjuvants, enhance the magnitude and change the bias of the immune responses to a herpesvirus glycoprotein.

  2002cites this paper
• Generation of Th1 immune responses to inactivated, gp120-depleted HIV-1 in mice with a dominant Th2 biased immune profile via immunostimulatory [correction of imunostimulatory] oligonucleotides--relevance to AIDS vaccines in developing countries.

  2002cites this paper
• Enhancement of the Immunoadjuvant Activity of Immunostimulatory DNA Sequence By Liposomal Delivery

  2002cites this paper
• Comparative efficacy of the Schistosoma mansoni nucleic acid vaccine, Sm23, following microseeding or gene gun delivery

  2002cites this paper
• Liposomal immunostimulatory DNA sequence (ISS-ODN): an efficient parenteral and mucosal adjuvant for influenza and hepatitis B vaccines.

  2002cites this paper
• Molecular aspects of allergy.

  2002cites this paper
• Regulation of gene expression in mouse macrophages stimulated with bacterial CpG‐DNA and lipopolysaccharide

  2002cites this paper
• Immunomodulatory Effects of CpG Oligodeoxynucleotides on Established Th2 Responses

  2002cites this paper
• Is Th1 the solution for Th2 in asthma?

  2002cites this paper
• Stimulation of B lymphocytes, macrophages, and dendritic cells by protozoan DNA.

  2002cites this paper